← Back to Search

Behavioral Intervention

Psychosocial Care for Advanced Cancer

N/A

Waitlist Available

Led By Anne Reb, NP, PhD

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Stage III or IV disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 9 months

Awards & highlights

Study Summary

This trial will test a new psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are afraid of their cancer progressing. CFS is based on a program called "Conquer Fear" which was developed by researchers in Australia. It may help reduce worries, fears, and uncertainty in patients with advanced lung or gynecological cancer.

Who is the study for?

This trial is for English-speaking patients with stage III-IV lung or gynecologic cancer who have been diagnosed at least 3 months ago. They must be undergoing treatment or active surveillance and feel a strong fear of their cancer progressing, as measured by specific questionnaires.Check my eligibility

What is being tested?

The Conquer Fear Support intervention is being tested to see if it can help reduce the fear and anxiety associated with advanced-stage lung or gynecological cancers. It includes psychoeducation, attention training, worry management, and detached mindfulness components.See study design

What are the potential side effects?

Since this is a psychosocial intervention focusing on mental health support rather than medication, there are no typical drug side effects. However, participants may experience emotional discomfort while discussing fears and anxieties.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My condition is in stage III or IV.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of the Conquer Fear SUPPORT (CFS) intervention is assessed by tracking attendance.

Feasibility of the Conquer Fear SUPPORT (CFS) intervention is assessed by tracking attrition.

Feasibility of the Conquer Fear SUPPORT (CFS) intervention is assessed by tracking enrollment rate.

Secondary outcome measures

Anxiety assessed using the PROMIS-Anxiety 8a

Cancer-specific distress assessed using the Impact of Event Scale-Revised (IES-R)

Depression assessed using the Patient Health Questionnaire (PHQ-9)

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (CFS)Experimental Treatment2 Interventions

Patients attend CFS psychosocial intervention consisting of 7 nurse-led sessions (session 1 in-person and sessions 2-7 via video conferencing) over 45 minutes each for 8 weeks. Patients also complete home practice assignments comprising attention training technique and mindfulness practice after each session. Patients complete self-report questionnaires at baseline (T1), 8 weeks (T2) and 12 weeks (T3).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor

565 Previous Clinical Trials

1,921,427 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,120 Total Patients Enrolled

Anne Reb, NP, PhDPrincipal InvestigatorCity of Hope Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what end is this clinical experiment striving?

"As the primary outcome, this clinical trial will use a 9 month window to assess the feasibility of Conquer Fear SUPPORT (CFS) by monitoring dropout rates. Secondary objectives include measuring fear of progression using Fear of Progression Questionnaire-Short Form (FOP-Q-SF), cancer specific distress through Impact Event Scale-Revised (IES-R), and overall symptom distress with Memorial Symptom Assessment Scale (MSAS)."

Answered by AI

Are there vacancies available for individuals to take part in this experiment?

"As evidenced by clinicaltrials.gov, this research study has ceased recruitment for the time being. Initially posted on November 15th 2018 and last updated February 17th 2022, it is currently not accepting participants - however there are 1,541 other trials actively seeking patients right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer

2018. "Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03776253.

All > Genital Warts